The staging evolution dilemma: TNM-9 sharpens anatomical precision, but is biology still offstage?
Open Access
- 30 June 2025
- journal article
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (3) , e20250236
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Validation of the 9th Tumor, Node, and Metastasis Staging System for Patients with Surgically Resected Non-Small Cell Lung CancerEuropean Journal of Cancer, 2025
- Prognostic impact of the N2 subclassification and stage migration in the ninth edition of the TNM classification in surgically resected lung cancerLung Cancer, 2024
- Prognostic Factors in Limited-Stage Small Cell Lung CancerJAMA Network Open, 2024
- American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung CancerJAMA Oncology, 2024
- The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2024
- Pathologic Assessment and Staging of Multiple Non–Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular MethodsLaboratory Investigation, 2024
- Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trialThe Lancet Oncology, 2022
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung CancerNew England Journal of Medicine, 2022
- Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialThe Lancet, 2021
- A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastasesPathology - Research and Practice, 2021